LEXARIA BIOSCIENCE CORP. (LEXX) Free cash flow 2016–2025
LEXARIA BIOSCIENCE CORP. (LEXX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$10.5MFY2025 · since FY2016: -$663,950 → -$10.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$10.5M | -109.4% |
| FY2024 | -$5.0M | +15.4% |
| FY2023 | -$5.9M | -20.0% |
| FY2022 | -$4.9M | — |
| FY2020 | -$2.6M | +28.3% |
| FY2019 | -$3.7M | — |
| FY2017 | -$1.5M | -132.8% |
| FY2016 | -$663,950 | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More LEXX financial trends
LEXX RevenueLEXX Net incomeLEXX Net marginLEXX Gross profitLEXX Gross marginLEXX Operating incomeLEXX Operating marginLEXX Operating cash flowLEXX Capital expendituresLEXX Return on equityLEXX Stock buybacksLEXX Dividends paidLEXX Total assetsLEXX Total liabilitiesLEXX Shareholders’ equityLEXX overview →